Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma. | Front Genet | 2023 | 36845378 | PubTator, text mining | PubMed |
| CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis. | Epigenetics | 2023 | 36840946 | PubTator, text mining | PubMed |
| Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 36835633 | PubTator, text mining | PubMed |
| Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics. | Cancers (Basel) | 2023 | 36831575 | PubTator, text mining | PubMed |
| RNA-Binding Proteins in Bladder Cancer. | Cancers (Basel) | 2023 | 36831493 | PubTator, text mining | PubMed |
| The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism. | Biomolecules | 2023 | 36830642 | PubTator, text mining | PubMed |
| Critical Roles of METTL3 in Translation Regulation of Cancer. | Biomolecules | 2023 | 36830614 | PubTator, text mining | PubMed |
| Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes. | Front Genet | 2023 | 36824434 | PubTator, text mining | PubMed |
| Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1/S phase arrest in colorectal cancer cells. | Chem Biol Interact | 2023 | 36822301 | PubTator, text mining | PubMed |
| The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection. | Oxid Med Cell Longev | 2023 | 36819785 | PubTator, text mining | PubMed |
| A computational map of the human-SARS-CoV-2 protein-RNA interactome predicted at single-nucleotide resolution. | NAR Genom Bioinform | 2023 | 36814457 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
| Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry. | Respir Res | 2023 | 36800958 | PubTator, text mining | PubMed |
| Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease. | Medicine (Baltimore) | 2023 | 36800593 | PubTator, text mining | PubMed |
| Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. | Heliyon | 2023 | 36798768 | PubTator, text mining | PubMed |
| Regulation of the tumor immune microenvironment by cancer-derived circular RNAs. | Cell Death Dis | 2023 | 36797245 | PubTator, text mining | PubMed |
| Emerging landscape of circFNDC3B and its role in human malignancies. | Front Oncol | 2023 | 36793611 | PubTator, text mining | PubMed |
| Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion. | Front Oncol | 2023 | 36793593 | PubTator, text mining | PubMed |
| Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation. | Aging (Albany NY) | 2023 | 36791151 | PubTator, text mining | PubMed |
| m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner. | Cell Death Dis | 2023 | 36781839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=41